title: Separation and quantitative recovery of mouse serum arylesterase and carboxylesterase activity.
abstract: Paraoxonase-1 (PON1) is known to be associated with high density lipoproteins. We optimized buffer conditions to obtain quantitative recovery of PON1 (arylesterase) activity and analyzed the distribution of PON1 in mice using a combination of size-exclusion chromatography and ultracentrifugation. Size-exclusion chromatography of mouse serum separated the esterase activity into two peaks, one overlapping the high density lipoproteins and a second peak of lower molecular weight, consistent with serum carboxylesterase, which accounted for approximately 20% of the total esterase activity of normal mouse serum. Using conditions for the quantitative recovery of arylesterase activity, we fractionated serum by ultracentrifugation into d < 1.21 g/ml, d < 1.25 g/ml, d > 1.21 g/ml, and d > 1.25 g/ml fractions. We observed that PON1 arylesterase activity and mass were isolated in the d < 1.21 g/ml fraction and that serum carboxylesterase was recovered in the d > 1.25 g/ml fraction. The significance of the confounding of PON1 arylesterase activity by serum carboxylesterase was demonstrated by studying mice challenged with a high-fat, high-cholate diet for 14 days. It was shown that all of the decrease in arylesterase activity in response to this diet is attributable to the HDL-associated arylesterase activity (PON1). We conclude that mouse PON1 is quantitatively associated with high density lipoproteins. The contribution of serum carboxylesterase to the total esterase activity significantly confounds the interpretation of total arylesterase activity in mouse serum.
authors.affiliation: Department of Medicine, University of Toronto, and St. Michael's Hospital, Toronto, Canada. connellyp@smh.toronto.on.ca
authors.forename: Philip W
authors.initials: PW
authors.lastname: Connelly
authors.forename: Graham F
authors.initials: GF
authors.lastname: Maguire
authors.forename: Dragomir I
authors.initials: DI
authors.lastname: Draganov
mesh_terms: D000284:Administration, Oral; D000818:Animals; D002265:Carboxylic Ester Hydrolases / Q000097:blood* / Q000302:isolation & purification* / Q000378:metabolism; D020355:Cholates / Q000008:administration & dosage / Q000494:pharmacology; D002791:Cholesterol, Dietary / Q000494:pharmacology; D008076:Cholesterol, HDL / Q000097:blood / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D013997:Time Factors; D014461:Ultracentrifugation
chemical_list: D020355:Cholates; D002791:Cholesterol, Dietary; D008076:Cholesterol, HDL; D002265:Carboxylic Ester Hydrolases; C019734:arylesterase